Financial Reporting - Zhejiang Galaxis Technology Group reported preliminary financial data for the year ending December 31, 2025, as per the Hong Kong Stock Exchange listing rules[2] - The financial information is available in the company's prospectus dated March 16, 2026, on the Hong Kong Stock Exchange website and the company's website[3] Governance Structure - The board of directors includes executive directors and independent non-executive directors, indicating a diverse governance structure[3]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 截至二零二五年十二月三十一日 止年度的全年業績 興業合金材料集團有限公司（「本公司」）董事會（「董事會」）欣然公佈本公司及其附屬公 司（統稱「本集團」）截至二零二五年十二月三十一日止年度的綜合業績，連同截至二零 二四年十二月三十一日止年度的比較數字如下： 綜合損益表 截至二零二五年十二月三十一日止年度 （以人民幣列示） | | | 二零二五年 | 二零二四年 | | --- | --- | --- | --- | | | 附註 | 人民幣千元 | 人民幣千元 | | 收益 | 4 | 9,259,024 | 8,053,401 | | 銷售成本 | | (8,346,693) | (7,291,849) | | 毛利 | | 912,331 | 761,552 | | 其他收入 | 5 | 63,597 | 35,385 | | 分銷費用 | | (73,197) | (67,900) | | 行政費用 ...

Financial Performance - Revenue for the year was approximately RMB 86.46 billion, a year-on-year increase of 0.1%[3] - Gross margin was approximately 7.8%, a decrease of 2.7 percentage points year-on-year[3] - Profit attributable to equity holders was approximately RMB 0.06 billion, a year-on-year decrease of 94.7%[3] - Core net profit was approximately RMB 0.26 billion, a year-on-year decrease of 83.5%[3] - Total operating revenue for the group in 2025 was RMB 86,457,288 thousand, compared to RMB 86,400,562 thousand in 2024, indicating a marginal increase of 0.1%[24] - The operating profit for the group was RMB 2,648,249 thousand, a decrease from RMB 3,451,169 thousand in the previous year[22] - The group reported a pre-tax profit of RMB 3,321,023 thousand, down from RMB 4,195,629 thousand year-on-year[22] - The total tax expense for 2025 was RMB 3,148,308 thousand, down from RMB 4,968,561 thousand in 2024, representing a decrease of approximately 36.6%[33] - The group reported a total borrowing cost of RMB 3,716,805 thousand in 2025, down from RMB 4,841,127 thousand in 2024, a decrease of about 23.2%[27] Sales and Contracted Sales - Total contracted sales amounted to approximately RMB 106.21 billion, a year-on-year decrease of 7.3%[4] - The cumulative contract sales amount for 2025 was approximately RMB 106.21 billion, a year-on-year decrease of 7.3%, with a total sales area of about 2.95 million square meters, down 24.7%[64] - In the core six cities, the contract sales reached approximately RMB 90.9 billion, accounting for 85.6% of the total contract sales[46] - The average price per square meter for contract sales in 2025 was RMB 36,000, an increase of 23.3% year-on-year[64] Assets and Liabilities - Cash and bank balances, including restricted deposits, totaled approximately RMB 46.76 billion, a decrease of 6.6%[5] - Total assets as of December 31, 2025, decreased to RMB 369,744,870 thousand from RMB 410,452,984 thousand in 2024, representing a decline of approximately 9.9%[23] - Current assets decreased to RMB 297,685,814 thousand in 2025 from RMB 340,791,865 thousand in 2024, representing a decline of about 12.6%[9] - Current liabilities decreased significantly to RMB 182,044,974 thousand in 2025 from RMB 220,514,657 thousand in 2024, a reduction of approximately 17.4%[10] - The total liabilities decreased from RMB 306,373,816 thousand in 2024 to RMB 263,912,482 thousand in 2025, a decrease of approximately 13.8%[10] - The company's equity attributable to shareholders remained stable at RMB 54,817,260 thousand in 2025 compared to RMB 55,261,066 thousand in 2024[10] Investments and Land Acquisition - The company acquired 25 new land parcels in 9 cities, with a total investment of approximately RMB 24.4 billion, focusing on core cities[4] - The company acquired 25 quality land parcels, adding approximately 2.78 million square meters of land reserves, with an investment amount of approximately RMB 24.4 billion[47] - As of the end of 2025, the total land reserves amounted to approximately 18.55 million square meters, with 94.4% concentrated in first and second-tier cities[48] Financing and Debt Management - The net gearing ratio was 54.9%, an increase of 3.2 percentage points year-on-year[5] - The weighted average borrowing interest rate was 3.05%, a decrease of 44 basis points year-on-year[5] - The company issued two domestic bonds totaling RMB 2.9 billion with coupon rates between 1.95% and 2.5%, and one offshore dim sum bond of RMB 2.85 billion with a coupon rate of 3.3%[50] - The company’s sustainable financing accounted for 35.0% of the total financing by year-end, with RMB 2.85 billion in green dim sum bonds issued[53] - The group has approximately HKD 143.4 billion (equivalent to RMB 129.5 billion) in bank loans denominated in HKD as of December 31, 2025[91] Operational Efficiency - The company's basic earnings per share for 2025 was RMB 0.0137, compared to RMB 0.2584 in 2024[38] - The group’s financial income was RMB 699,179 thousand, while financial expenses totaled RMB 828,323 thousand[22] - The group's share of net profit from joint ventures in 2025 was approximately RMB 1.219 billion, up from RMB 1.021 billion in 2024, mainly driven by net investment income from cooperative projects[79] - The group’s operating costs not allocated amounted to RMB 36,316 thousand, down from RMB 103,675 thousand in the previous year[22] Market Position and Strategy - The company aims to strengthen its market position in the Greater Bay Area and achieve sales targets of RMB 100 billion while ensuring financial stability and maintaining investment-grade credit ratings[57] - The group plans to continue implementing policies to stabilize the economy and the real estate market in response to ongoing economic challenges[91] - The company is focused on enhancing property services and expanding value-added services to achieve high-quality growth[58] Employee and Workforce - The group employs approximately 14,000 employees as of December 31, 2025, down from 14,940 employees as of June 30, 2025[95]

Financial Performance - Revenue for the year ended December 31, 2025, was RMB 5,125,504 thousand, a decrease of 25.2% compared to RMB 6,850,721 thousand in 2024[2] - Operating profit increased by 87.3% to RMB 412,529 thousand from RMB 220,291 thousand year-on-year[2] - Adjusted net profit under non-IFRS increased by 24.5% to RMB 291,821 thousand from RMB 234,393 thousand in 2024[2] - Net profit for the reporting period was approximately RMB 280.9 million, an increase of 29.7% compared to RMB 216.6 million in 2024[26] - The company's revenue for the reporting period was approximately RMB 5,125.5 million, a decrease of 25.2% compared to RMB 6,850.7 million in 2024[13] - Gross profit decreased by 23.3% from RMB 3,342.7 million in 2024 to approximately RMB 2,563.5 million, while the gross margin increased from 48.8% to 50.0%[15] - The income tax expense increased by 184.3% to approximately RMB 90.0 million due to the increase in operating profit[25] - The adjusted net profit for the year ended December 31, 2025, was RMB 291.8 million, an increase of 24.5% from RMB 234.4 million in 2024[27] - The company's revenue for the year ended December 31, 2025, was RMB 5,125,504 thousand, a decrease of 25.2% compared to RMB 6,850,721 thousand in 2024[58] - The value-added services revenue decreased to RMB 3,656,052 thousand in 2025 from RMB 5,037,732 thousand in 2024, representing a decline of 27.3%[58] - The total expenses for the year ended December 31, 2025, were RMB 5,066,354 thousand, down 22.3% from RMB 6,517,819 thousand in 2024[59] - The net profit attributable to the company's owners increased to RMB 241,196 thousand in 2025, up 33.8% from RMB 180,312 thousand in 2024[61] - Basic earnings per share rose to RMB 0.13 in 2025 from RMB 0.10 in 2024, reflecting a growth of 30%[61] User Engagement and Growth Strategy - Monthly average active users decreased by 10.8% to 18,583 thousand from 20,836 thousand in 2024[4] - The average revenue per user decreased by 4.4% to RMB 26.2 from RMB 27.4 in 2024[4] - The company aims to leverage AI technology to enhance user interaction and content production, focusing on sustainable growth[5] - The company plans to expand its overseas operations, particularly in Southeast Asia and the Middle East, to drive scalable growth[7] - The company is exploring innovative interactive experiences through AI technology to enhance user engagement[8] - The company anticipates a shift from scale-driven growth to a dual focus on value and efficiency in its operations[8] - The company is committed to a long-term strategy of optimizing its live social business ecosystem amidst changing macroeconomic conditions[5] Financial Position and Liquidity - The current ratio as of December 31, 2025, was 5.3, up from 3.7 on December 31, 2024, indicating improved liquidity[28] - Cash and cash equivalents amounted to approximately RMB 2,117.6 million as of December 31, 2025, a decrease from RMB 2,195.7 million in 2024[29] - The total financial assets measured at fair value through profit or loss were approximately RMB 974.1 million as of December 31, 2025, compared to RMB 759.4 million in 2024, reflecting a growth of 28.2%[30] - Restricted cash balance as of December 31, 2025, was approximately RMB 203.5 million, down from RMB 319.6 million in 2024, reflecting a decrease in liquidity[29] - The debt-to-equity ratio was 0.2 as of December 31, 2025, a decrease from 0.3 on December 31, 2024, indicating a reduction in leverage[28] - The company has approximately RMB 28.5 million in bank deposits frozen due to an ongoing investigation by local regulatory authorities[35] - The company has pledged approximately RMB 162 million in restricted cash as collateral for bank loans, with no other assets pledged[36] Research and Development - Research and development expenses decreased by 22.5% from RMB 202.2 million in 2024 to approximately RMB 156.8 million[18] - The company is actively embracing AI technology innovations and exploring new business opportunities in the Web3.0 and advanced technology sectors[10] - The company has a systematic training and development plan aimed at enhancing employee skills and supporting sustainable growth[38] Corporate Governance and Compliance - The company has adopted the corporate governance code and complied with all applicable provisions during the reporting period[73] - The company is led by Mr. Feng You Sheng, who serves as both Chairman and CEO, emphasizing the importance of unified leadership for strategic planning and management since its establishment in 2015[74] - The company has adopted the standard code of conduct for securities transactions by directors, confirming compliance during the reporting period[76] - The independent auditor, PwC, has verified the consolidated financial statements for the reporting period, although their work does not constitute a certification under Hong Kong accounting standards[77] - An audit committee has been established, consisting of three independent non-executive directors, to oversee the annual performance review[78] - The annual performance announcement and annual report will be published on the Hong Kong Stock Exchange and the company's website, ensuring transparency[81] Events and Future Outlook - The company plans to adopt new accounting standards effective January 1, 2025, which may impact financial reporting but is not expected to significantly affect financial performance[55] - The company is evaluating the potential impacts of new accounting standards on its financial performance and reporting structure[56] - No significant events occurred after the reporting period and up to the performance announcement date, indicating stability[80]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 Yonghe Medical Group Co., Ltd. 雍禾醫療集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2279） (I) 截至2025年12月31日止年度的年度業績公告 及(II) 所得款項用途改變 財務摘要 本集團的收入由截至2024年12月31日止年度的人民幣1,804.5百萬元增加0.2%至 截至2025年12月31日止年度的人民幣1,808.3百萬元。 本集團的毛利由截至2024年12月31日止年度的人民幣1,084.2百萬元增加10.1% 至截至2025年12月31日止年度的人民幣1,194.2百萬元。 毛利率由截至2024年12月31日止年度的60.1%增加至截至2025年12月31日止年 度的66.0%。 截至2024年12月31日止年度本集團的淨虧損為人民幣226.6百萬元，而截至 2025年12月31日止年度本集團的淨利潤為人民幣73.6百萬元。 本集團的除 ...

Financial Performance - For the fiscal year ending December 31, 2025, the total revenue was $154,208,000, a decrease of 3.4% compared to $159,575,000 in 2024[4] - The gross profit for 2025 was $12,254,000, a significant improvement from a gross loss of $13,906,000 in 2024[4] - The net loss for the year was $328,050,000, which represents a 17.6% reduction from the net loss of $398,195,000 in 2024[4] - Adjusted net loss decreased by 24.0% to $63,012,000 in 2025 from $82,899,000 in 2024[4] - Revenue for the year ended December 31, 2025, was $154,208,000, a decrease of 3.6% compared to $159,575,000 for the year ended December 31, 2024[19] - Revenue from Advanced Driver Assistance Systems (ADAS) was $133,075,000, down 11.4% from $150,110,000 in the previous year[19] - Revenue from robotics and others increased significantly to $18,912,000 from $8,233,000, representing a growth of 129.5%[19] - The company reported a pre-tax loss of $328,050,000 for the year ending December 31, 2025, compared to a loss of $398,195,000 for the previous year[31] - The gross margin improved from -8.7% in 2024 to 7.9% in 2025, marking the first positive annual gross margin for the company[47] - Basic and diluted loss per share improved from $(1.67) in 2024 to $(1.10) in 2025[62] Assets and Liabilities - Total current assets increased by 79.6% to $227,535,000 in 2025 from $126,707,000 in 2024[6] - Total assets rose by 49.5% to $264,049,000 in 2025 compared to $176,670,000 in 2024[6] - Total liabilities decreased significantly by 80.9% to $218,882,000 in 2025 from $1,148,693,000 in 2024[6] - The equity position improved to $45,167,000 in 2025 from a deficit of $972,023,000 in 2024[6] - The asset-liability ratio as of December 31, 2025, was 82.9%, a significant decrease from 650.2% as of December 31, 2024[86] Cash Flow and Financing - Cash and cash equivalents, along with restricted bank balances, increased to $119.5 million as of December 31, 2025, from $51.5 million as of December 31, 2024[78] - Net cash used in operating activities was $70.1 million for the reporting period, an increase from $46.5 million for the year ending December 31, 2024[79] - The net cash used in investing activities during the reporting period was $21.9 million, an increase from $7.2 million for the year ended December 31, 2024[80] - The net cash from financing activities was $154.5 million, mainly from PIPE and PEF investors amounting to $112.4 million after deducting transaction costs, along with new borrowings of $54.8 million[81] - As of December 31, 2025, the total borrowings amounted to $65.4 million, with $22.6 million secured and $42.8 million unsecured, primarily used for operational funding[82] Research and Development - Research and development expenses increased to $40,361,000 in 2025 from $36,958,000 in 2024, indicating ongoing investment in innovation[7] - Research and development expenses totaled $40,361,000 for the year ending December 31, 2025, compared to $36,958,000 in 2024[24] - Research and development expenses increased by 9.2% from $37.0 million for the year ending December 31, 2024, to $40.4 million for the year ending December 31, 2025, primarily due to new project-related expenses[68] Market and Product Development - The company is focused on developing high-performance LiDAR solutions for smart transportation and infrastructure applications[10] - The global automotive-grade LiDAR market is projected to grow from $2.2 billion in 2025 to $3.21 billion by 2030, indicating a compound annual growth rate (CAGR) of approximately 36.5%[42] - The non-automotive LiDAR market is expected to expand from $1.3 billion in 2025 to $9.2 billion by 2030, reflecting a CAGR of around 49.5%[42] - The company has deployed over 700,000 units of its Falcon LiDAR, which is currently in mass production[41] - The proprietary OmniVidi software platform has been developed to work with the company's LiDAR hardware, enabling customers to process detected raw information[44] - The company has established a comprehensive product portfolio that includes LiDAR sensor hardware and proprietary software solutions tailored for various applications[44] - The company has established strategic partnerships with 17 additional OEMs and ADAS/ADS companies, focusing on L2+/L3 level intelligent driving plans, covering over 50 vehicle models by December 31, 2025[45] Employee and Operational Costs - The company reported a significant increase in employee costs, including stock-based compensation, which rose to $8,384,000 in 2025 from $786,000 in 2024[24] - Employee compensation expenses totaled $60.2 million during the reporting period, up from $51.2 million for the year ended December 31, 2024[97] - Sales and marketing expenses rose by 53.5% from $8.2 million in 2024 to $12.6 million in 2025, driven by increased employee benefits and headcount[66] - Administrative expenses increased by 21.6% from $21.4 million in 2024 to $26.0 million in 2025, primarily due to higher salaries and employee benefits[67] Corporate Governance and Compliance - The company has established an ESG committee effective from December 10, 2025, chaired by Dr. Costas John Spanos, to oversee ESG strategies and performance[109] - The company has formed an audit committee consisting of three independent non-executive directors to review financial reporting and internal controls[103] - The company aims to implement high standards of corporate governance to protect shareholder interests[99] - The board of directors has not recommended the declaration of a final dividend for the reporting period[106] - There were no significant events requiring disclosure after the reporting period up to the announcement date[105] Special Purpose Acquisition Company (SPAC) Transactions - The company incurred $57,085,000 in expenses related to special purpose acquisition company (SPAC) merger transactions[25] - The fair value of the consideration for the SPAC merger was approximately $47,043,000, with identifiable assets and liabilities of Techstar valued at $15,180,000[26] - Professional fees and expenses related to special purpose acquisition company (SPAC) transactions were $7.1 million in 2025, compared to $2.5 million in 2024[72]

Financial Performance - The preliminary financial performance for the year ending December 31, 2025, has been disclosed in the prospectus dated March 23, 2026[3]. Stock Information - The company is listed under stock code 0664 on the Hong Kong Stock Exchange[2]. Compliance and Governance - The announcement is made in compliance with the Hong Kong Stock Exchange's Listing Rules, specifically rule 13.49(1)[3]. - The board of directors includes executive directors and independent non-executive directors, ensuring a diverse governance structure[3].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 會 就 本 公 告 全 部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 BUSY MING GROUP CO., LTD. 湖南鳴鳴很忙商業連鎖股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：1768） 截 至2025年12月31日止年度 年度業績公告 湖南鳴鳴很忙商業連鎖股份有限公司（「本公司」，連 同 其 附 屬 公 司，統 稱「本 集 團」）董 事（「董 事」）會（「董事會」）欣然宣佈本集團截至2025年12月31日止年度（「報 告 期」）按 照 國 際 財 務 報 告 準 則 編 製 的 綜 合 年 度 業 績 及 財 務 狀 況，連 同 截 至2024 年12月31日 止 年 度 的 比 較 數 字。該 等 業 績 已 由 董 事 會 審 核 委 員 會（「審核委員 會」）審 閱。 除 本 公 告 另 有 界 定 者 外，本 公 告 內 所 用 ...

Financial Performance - The revenue for LifeTech Scientific Corporation for the year ended December 31, 2025, was approximately RMB 1,369.8 million, an increase of about RMB 66.1 million or approximately 5.1% compared to RMB 1,303.7 million in 2024, primarily due to increased sales of coated stents[3] - The gross profit for the same period was approximately RMB 1,019.1 million, up about 3.8% from RMB 981.4 million in 2024[3] - The net profit, excluding certain non-recurring items, was approximately RMB 353.4 million, representing a growth of about 24.9% from RMB 283.0 million in 2024[3] - The company reported a decrease in net profit attributable to owners of the company to approximately RMB 147.8 million, down about 33.5% from RMB 222.4 million in 2024, mainly due to increased share-based payment expenses and income tax expenses[3] - The total comprehensive income for the year was approximately RMB 142.0 million, compared to RMB 71.4 million in 2024[4] - The company reported a pre-tax profit of RMB 191,454,000 for the year ending December 31, 2025, compared to RMB 198,995,000 for the previous year, indicating a slight decline of about 3.1%[19] - The company’s basic earnings per share for the year was RMB 3.4 cents, down from RMB 5.1 cents in 2024[4] - The company's profit before tax for 2025 is RMB 502,227,000, an increase of 7.3% from RMB 467,863,000 in 2024[29] Expenses and Liabilities - Research and development expenses for the year were approximately RMB 242.7 million, a decrease from RMB 302.9 million in 2024[4] - The total liabilities for the operating segments increased from RMB 331,612 thousand in 2024 to RMB 386,681 thousand in 2025, representing a rise of about 16.6%[22] - Employee costs, including director remuneration, totaled RMB 259,295,000 in 2025, down from RMB 283,502,000 in 2024, reflecting a decrease of 8.5%[29] - The total income tax expense for 2025 is RMB 79,076,000, significantly higher than RMB 30,504,000 in 2024, representing an increase of 159.5%[30] - The company reported a total depreciation and amortization expense of RMB 80,831,000 in 2025, up from RMB 74,905,000 in 2024, marking an increase of 7.5%[29] Cash and Assets - The company’s cash and cash equivalents amounted to approximately RMB 719.3 million, compared to RMB 665.8 million in 2024[5] - The total assets less current liabilities as of December 31, 2025, were approximately RMB 3,533.0 million, down from RMB 4,084.7 million in 2024[5] - The total current assets as of December 31, 2025, are approximately RMB 2,325.1 million, a slight decrease from RMB 2,334.2 million as of December 31, 2024[87] - The total current liabilities as of December 31, 2025, are approximately RMB 1,479.4 million, significantly increasing from RMB 815.6 million as of December 31, 2024[87] - The company’s current ratio as of December 31, 2025, is approximately 1.57, down from 2.86 as of December 31, 2024[87] Revenue Segmentation - The structural heart business generated RMB 511,676,000 in sales, while the peripheral vascular business contributed RMB 844,628,000, and the electrophysiology business accounted for RMB 13,475,000 in the year ending December 31, 2025[17] - Revenue from external customers in mainland China rose to RMB 973,350 thousand in 2025, up from RMB 957,105 thousand in 2024, an increase of approximately 1.3%[25] - The company’s domestic sales increased by approximately 1.7% compared to the same period in 2024, with the domestic market accounting for about 71.1% of total revenue[55] - The company’s overseas sales increased by approximately 14.4% compared to the same period in 2024, primarily due to active expansion of overseas business and effective marketing strategies[55] Investments and Innovations - The company is focused on the development of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases, with ongoing research and development efforts in these areas[11] - The company submitted 271 patent applications and registered 168 patents during the year, with a cumulative total of 2,631 valid patent applications and 1,217 registered patents as of December 31, 2025[61] - The company is actively pursuing new product registrations and clinical trials for various innovative medical devices, including the CeraTM ceramic membrane closure device and the IBS TitanTM absorbable drug-eluting peripheral stent system[64] - The company has developed a fourth-generation congenital heart defect occluder to meet diverse patient needs, indicating a commitment to innovation in its structural heart disease business[103] Corporate Governance and Compliance - The board of directors recommended not to declare any final dividend for the year ended December 31, 2025[3] - The company has adopted a standard code for securities trading by directors and confirmed compliance for the fiscal year ending December 31, 2025[126] - Deloitte has been the auditor for the company for the past three years, and the resolution for their reappointment will be presented at the upcoming annual general meeting[127] - The audited financial performance for the year ending December 31, 2025, has been reviewed by the audit committee, confirming compliance with applicable accounting standards and sufficient disclosure[131] Market and Strategic Focus - The company plans to continue expanding its market presence in Europe and Asia, with specific focus on increasing sales in the peripheral vascular and structural heart segments[11] - The company has a distribution network covering numerous countries across Asia, Europe, North America, South America, and Africa[54] - The market demand for peripheral vascular disease products is expected to continue growing due to aging population and increased disease detection rates[104] - The company plans to maintain a prudent capital allocation strategy to ensure sustainable growth while actively seeking collaboration opportunities with companies that have strong market potential[111]

Financial Performance - The company reported its annual performance for the year ending December 31, 2025, in accordance with the Hong Kong Stock Exchange's listing rules[3]. - The company's operating revenue for 2025 was ¥6,186,550,243.97, a decrease of 72.78% compared to ¥22,729,474,852.76 in 2024[18]. - The net profit attributable to shareholders for 2025 was -¥8,295,932,402.88, representing an 11.94% increase in losses from -¥7,410,784,491.65 in 2024[18]. - The net cash flow from operating activities for 2025 was ¥243,208,407.71, a decline of 90.73% from ¥2,623,191,664.60 in 2024[18]. - The total assets at the end of 2025 were ¥50,620,148,908.13, down 20.29% from ¥63,509,295,142.08 at the end of 2024[18]. - The net assets attributable to shareholders decreased by 90.13% to ¥903,835,592.13 at the end of 2025 from ¥9,156,104,358.91 at the end of 2024[18]. - The basic earnings per share for 2025 was -¥2.83, a decrease of 11.86% from -¥2.53 in 2024[18]. - The weighted average return on net assets for 2025 was -164.83%, a decrease of 107.58 percentage points from -57.25% in 2024[18]. - The company reported a significant decline in revenue from other business activities, with income from non-main business activities dropping to ¥68,753,596.86 in 2025 from ¥159,980,820.39 in 2024[19]. - The company experienced a quarterly loss in net profit, with the fourth quarter showing a loss of -¥2,288,115,849.71[23]. Dividend and Shareholder Information - The board of directors proposed not to distribute a final dividend for the fiscal year 2025, pending shareholder approval at the annual general meeting on May 15, 2026[6]. - The company has a history of unremitted losses at the parent company level, which may affect future dividend distributions[11]. - The annual report will be available for shareholders and can be accessed on the Hong Kong Stock Exchange and the company's website starting March 30, 2026[3]. - The available reserves for cash distribution as of December 31, 2025, are RMB 0.00, a decrease from RMB 1.086 billion in 2024[135]. Strategic Focus and Future Plans - The company plans to focus on market expansion and new product development as part of its future strategy[10]. - The company is focusing on cost reduction and efficiency improvement, with a significant decrease in financial expenses compared to the previous year, aided by negotiations with 90 out of 109 financial institutions for interest rate reductions or extensions[33]. - The company plans to implement a "one-two-five" development strategy in 2026, focusing on enhancing benefits through cadre team construction, improving the industrial ecosystem, and deepening reform and innovation[36]. - The company aims to enhance its production management system through digital transformation and automation, focusing on improving operational efficiency and risk control by upgrading key processes by 2026[101]. - The company will focus on brand and credibility enhancement as a core strategy, aiming to improve market recognition and customer loyalty through quality control and high-value product development by 2026[104]. Operational Challenges and Risks - The company faces risks related to macroeconomic fluctuations, national policies, and industry competition, which may impact future performance[10]. - The company has indicated uncertainty regarding its ability to continue as a going concern, as both net profits before and after deducting non-recurring gains and losses have been negative in recent years[19]. - The company has experienced operational challenges due to production halts at its Shouguang and Zhanjiang bases, impacting overall revenue and efficiency[96]. - The paper industry faces intensified competition, with structural oversupply in certain product categories leading to downward price pressure, particularly on white cardboard[111]. Governance and Management - The company has established a special investment fund, Chenming Huanggang Fund, for the construction of its subsidiary Huanggang Chenming Phase II project, with a 59.97% stake held by Zhanjiang Chenming as a limited partner[159]. - The company has adjusted its governance structure by eliminating the supervisory board, with the audit committee of the board taking over its responsibilities, ensuring compliance with the latest regulatory requirements[171]. - The board of directors consists of 11 members, including 5 executive directors (1 employee representative), 2 non-executive directors, and 4 independent directors, with a total of 8 board meetings held during the reporting period[174]. - The company maintains complete independence from its controlling shareholders in terms of business, personnel, assets, organization, and finance, with no interference in operational decisions[178]. - The company has implemented strict information disclosure practices, enhancing the quality of disclosures and ensuring compliance with insider information management regulations[176]. Research and Development - The company is developing several new technologies, including dual-coating technology for anti-stick base paper and specialized copperplate paper for packaging boxes, aiming for domestic leadership[70]. - The company plans to increase R&D investment and strengthen technological innovation capabilities as production operations stabilize[71]. - The company has received over 490 national patent authorizations, including 45 invention patents, and has been recognized with 16 provincial-level technology advancement awards[53]. Environmental and Sustainability Initiatives - The company has invested over RMB 8 billion in environmental protection measures, including advanced pollution control systems, and has implemented a leading wastewater reuse project in the industry[54]. - The company is committed to green production, increasing environmental investments and upgrading facilities to create a resource-saving and environmentally friendly enterprise[40]. - Environmental risks are acknowledged, with the company committed to integrating green development practices and achieving a water reuse rate of over 75% through advanced filtration technologies[109]. Financial Management and Capital Structure - The company has initiated a debt restructuring plan to negotiate extended repayment terms and lower interest rates, ensuring sufficient operational funds[120]. - The company is addressing financial risks by optimizing asset structure, increasing cash flow, and enhancing communication with financial institutions to alleviate debt pressure[113]. - The company has pledged fixed assets worth ¥39,673,397,581.16 as collateral for bank loans and long-term payables[85]. - The company plans to use the net proceeds from the divestment to repay its debts according to the payment schedule outlined in the agreement[167].